|
|||||
|
|
Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.) |
|
| Authors: | Emanuela Palmerini MD PhD Peter Reichardt MD Kirsten Sundby Hall MD Rossella Bertulli MD Stefan S. Bielack MD Alessandro Comandone MD Gerlinde Egerer MD Anna Hansmeier MD Matthias Kevric MD Elisa Carretta MD Lina Hansson MD Nina Jebsen MD Mikael Eriksson MD Øyvind S. Bruland MD Davide Maria Donati MD PhD Toni Ibrahim MD PhD Sigbjørn Smeland MD Stefano Ferrari MD |
| Affiliation: | 1. Osteoncology, Bone and Soft Tissue Sarcomas, and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy;2. Sarcoma Center, Helios Klinikum Berlin-Buch, Berlin, Germany;3. Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway;4. Adult Mesenchymal Tumor Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy;5. Cooperative Osteosarcoma Study Group, Klinikum Stuttgart–Olgahospital, Stuttgart, Germany;6. SC Oncologia Azienda Sanitaria Locale “Città di Torino” Ospedale San Giovanni Bosco Torino, Turin, Italy;7. University Hospital Heidelberg, Heidelberg, Germany;8. Department of Hematology and Oncology, University Hospital Münster, Munster, Germany;9. Department of Programming and Monitoring, IRCCS Istituto Ortopedico RizzolI, Bologna, Italy;10. Sahlgrenska University Hospital, Gothenburg, Sweden;11. Haukeland University Hospital, Bergen, Norway;12. Skåne University Hospital, Lund, Sweden;13. Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway Institute of Clinical Medicine, University of Oslo, Oslo, Norway;14. Orthopedic Oncology, IRCCS Istituto Ortopedico RizzolI, Bologna, Italy;15. Institute of Clinical Medicine, University of Oslo, Oslo, Norway Division of Cancer Medicine and Scandinavian Sarcoma Group, Oslo University Hospital, Oslo, Norway |
| Abstract: | |
| Keywords: | angiosarcoma bone sarcoma chemotherapy fibrosarcoma leiomyosarcoma multimodality treatment nonosteosarcoma malignant bone tumors rare primary malignant bone sarcoma (RPMBS) ultra-rare sarcoma undifferentiated pleomorphic sarcoma |